EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RCA-I-resistant CHO mutant cells have dysfunctional GnT I and expression of normal GnT I in these mutants enhances sialylation of recombinant erythropoietin



RCA-I-resistant CHO mutant cells have dysfunctional GnT I and expression of normal GnT I in these mutants enhances sialylation of recombinant erythropoietin



Metabolic Engineering 12(4): 360-368



A large number of CHO glycosylation mutants were isolated by Ricinus communis agglutinin-I (RCA-I). Complementation tests revealed that all these mutant lines possessed a dysfunctional N-acetylglucosaminyltransferase I (GnT I) gene. Sequencing analyses on the GnT I cDNAs isolated from 16 mutant lines led to the identification of nine different single base pair mutations. Some mutations result in a premature stop codon whereas others cause a single amino acid substitution in the GnT I protein. Interestingly, expression of the normal GnT I cDNA in mutant cells resulted in enhanced sialylation of N-glycans. The sialylation of recombinant erythropoietin (EPO) produced in mutant cells that were co-transfected with GnT I was enhanced compared to that of EPO produced in wild type CHO cells. The enhanced sialylation of EPO produced by JW152 cells in the presence of GnT I over CHO-K1 cells is a result of increased sialylated glycan structures with higher antennary branching. These findings represent a new strategy that may be utilized by the biotechnology industry to produce highly sialylated therapeutic glycoproteins.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333717

Download citation: RISBibTeXText

PMID: 20346410

DOI: 10.1016/j.ymben.2010.03.002



Related references

Enhanced sialylation of recombinant erythropoietin in CHO cells by human glycosyltransferase expression. Journal of Microbiology and Biotechnology 18(12): 1945-1952, 2009

Enhanced sialylation of recombinant erythropoietin in genetically engineered Chinese-hamster ovary cells. Biotechnology and Applied Biochemistry 52(Pt 4): 283-291, 2008

Recombinant human erythropoietin increases interleukin-1 beta production in cultured peripheral blood mononuclear cells from patients resistant to recombinant human erythropoietin therapy. Nephron 67(2): 245-247, 1994

Enhanced sialylation of recombinant human erythropoietin in Chinese hamster ovary cells by combinatorial engineering of selected genes. Glycobiology 21(8): 1019-1028, 2012

Producing recombinant therapeutic glycoproteins with enhanced sialylation using CHO-gmt4 glycosylation mutant cells. Bioengineered 5(4): 269–73-269–73, 2015

Caspase activation, sialidase release and changes in sialylation pattern of recombinant human erythropoietin produced by CHO cells in batch and fed-batch cultures. Cytotechnology 51(2): 67-79, 2008

Genetic recombination with poliovirus type 1. Studies of crosses between a normal horse serum-resistant mutant and several guanidine-resistant mutants of the same strain. Virology 20: 107-119, 1963

Structural analysis of the sialylated N- and O-linked carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells: Sialylation patterns and branch location of dimeric N-acetyllactosamine units. European Journal of Biochemistry 228(3): 981-1008, 1995

Comparison of biological activity and safety of recombinant canine erythropoietin with that of recombinant human erythropoietin in clinically normal dogs. American Journal of Veterinary Research 60(5): 636-642, 1999

Novel baculovirus expression vectors that provide sialylation of recombinant glycoproteins in lepidopteran insect cells. Journal of Virology 75(13): 6223-6227, 2001

Production of recombinant human hyperglycosylated erythropoietin using cell culture technology by improving sialylation. Korean Journal of Microbiology & Biotechnology 32(2): 142-148, June, 2004

Effect of recombinant human growth factors: recombinant human interleukin-6, recombinant human granulocyte-macrophage colony-stimulating-factor and recombinant human erythropoietin on normal human hematopoietic progenitor cells. Zhonghua Nei Ke Za Zhi 33(5): 298-301, 1994

The dysfunctional LDL receptor in a monensin-resistant mutant of Chinese hamster ovary cells lacks selected O-linked oligosaccharides. Archives of Biochemistry and Biophysics 284(2): 245-256, 1991

High-level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella (SE(B-fuc-t (SE(B-xyl-t mutant. Plant biotechnology journal 5(3): 389-401, 2007